Skip to main content

DIADEMA PARTNERS LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in TGTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,874,148
+$3,199,082 QoQ
Shares Held
206,928
+67.8% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
3.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$2,981,000
PutShares
100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. TGTX ranks #10 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TGTX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,874,148 206,928
2025-12-31 $3,675,066 123,283
2025-12-31 $2,981,000 100,000
2025-09-30 $2,194,521 60,748
2025-06-30 $13,368,413 371,448
2025-03-31 $8,196,826 207,883
2024-12-31 $6,020,000 200,000
2024-12-31 $1,438,930 47,805